The proportion of very-low-birthweight neonates ( < 1500 g ) was significantly lower in the 17OHPC group ( 7.6 % ) compared with placebo ( 14.3 % ) ( relative risk , RR 0.5 ; 95 % confidence interval , 95 % CI 0.3-0 .9 ; P = 0.01 ) .